AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mainglic M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sarmain Pharmaceuticals

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Mainglic M 80mg/500mg Tablet

Metformin/glimepiride 80mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication even with controlled blood sugar; abrupt cessation without medical supervision can elevate blood glucose, increasing the risk of complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting glucose source (e.g., sugary foods or juice) to manage hypoglycemia, and maintain regular mealtimes. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Mainglic M 80mg/500mg Tablet

There is no text provided to rephrase.

Uses of Mainglic M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Mainglic M 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Mainglic M 80mg/500mg Tablet with a meal.

Common Side effects of Mainglic M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Mainglic M 80mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Mainglic M 80mg/500mg Tablet whole; avoid chewing, crushing, or fracturing. Consume this medication with a meal.

How Mainglic M 80mg/500mg Tablet works:

Gliclazide and metformin, at doses of 80mg and 500mg respectively, are combined in Mainglic M tablets to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Mainglic M 80mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Mainglic M 80mg/500mg tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Mainglic M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Mainglic M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For individuals with severe kidney disease, this medication is contraindicated. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Mainglic M 80mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, initiation with a reduced Mainglic M 80mg/500mg tablet dosage is typical; however, it's contraindicated in those with severe hepatic dysfunction.

What if you forget to take Mainglic M 80mg/500mg Tablet :

Should you forget a Mainglic M 80mg/500mg Tablet dose, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.

Facts to Know About Mainglic M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Mainglic M 80mg/500mg Tablet

Mainglic M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Mainglic M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Mainglic M 80mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Mainglic M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, Metformin-associated lactic acidosis). This rare side effect is best avoided in older adults, individuals with kidney problems, and heavy alcohol users. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Mainglic M 80mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Mainglic M 80mg/500mg Tablet is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Mainglic M 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Mainglic M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Mainglic M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Mainglic M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Mainglic M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is best avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Mainglic M 80mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Mainglic M 80mg/500mg Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Mainglic M 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Mainglic M 80mg/500mg Tab...
30
MRP 37
18% off